World's Best Scientists 2026 revealed!
Håkan Olsson

Håkan Olsson

Award Badge
Medicine
Sweden
2023

D-Index & Metrics

Medicine

D-Index
123
Citations
70320
World Ranking
3297
National Ranking
67

Research.com Recognitions

  • 2023 - Research.com Medicine in Sweden Leader Award

Overview

Håkan Olsson is affiliated with Lund University in Sweden, focusing on research within biochemistry, genetics, and molecular biology. Their work spans various interconnected domains, particularly emphasizing genetics and oncology.

The main fields of study include:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Subfields of particular interest in their work are:

  • Genetics
  • Oncology
  • Molecular Biology
  • Immunology
  • Cancer Research

The research topics they frequently address cover:

  • BRCA gene mutations in cancer
  • Genetic Associations and Epidemiology
  • Nutrition, Genetics, and Disease
  • Cancer Immunotherapy and Biomarkers
  • Cutaneous Melanoma Detection and Management
  • Cancer Risks and Factors
  • Estrogen and related hormone effects

Among their recent publications are:

  • "Tertiary lymphoid structures improve immunotherapy and survival in melanoma", 2020, Nature
  • "Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility", 2020, Nature Genetics
  • "Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine", 2021, Translational Oncology
  • "Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk", 2020, JNCI Journal of the National Cancer Institute
  • "Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers", 2020, Breast Cancer Research

Frequent collaborators in their research include:

  • D. Gareth Evans
  • Graham G. Giles
  • Manjeet K. Bolla
  • Roger L. Milne
  • Niclas Håkansson

Olsson often publishes in venues such as:

  • JNCI Journal of the National Cancer Institute
  • Scientific Reports
  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries
  • Nature

Best Publications

  • Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies

    A. Antoniou;P.D.P. Pharoah;S. Narod;H.A. Risch

  • Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer

    E. E. Calle;C. W. Heath;R. J. Coates;J. M. Liff

  • Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

    Karoline B. Kuchenbaecker;Karoline B. Kuchenbaecker;John L. Hopper;Daniel R. Barnes;Kelly-Anne Phillips

  • Tertiary lymphoid structures improve immunotherapy and survival in melanoma.

    Rita Cabrita;Martin Lauss;Adriana Sanna;Marco Donia

  • Gene-Expression Profiles in Hereditary Breast Cancer

    I Hedenfalk;D Duggan;Y Chen;M Radmacher

  • Cancer risks in BRCA2 mutation carriers

    Håkan Olsson

  • Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease

    Torgil Möller;Håkan Olsson;Jonas Ranstam

  • Breast cancer and hormonal contraceptives : collaborative reanalysis of individual data on 53.297 women with breast cancer and 100.239 women without breast cancer from 54 epidemiological studies

    E. E. Calle;C. W. Heath;H. L. Miracle-McMahill;R. J. Coates

  • Association analysis identifies 65 new breast cancer risk loci

    Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley

  • Alcohol, tobacco and breast cancer - Collaborative reanalysis of individual data from 53 epidemiological studies, including 58 515 women with breast cancer and 95 067 women without the disease

    N Hamajima;K Hirose;K Tajima;T Rohan

  • Menarche, menopause, and breast cancer risk: Individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies

    N. Hamajima;K. Hirose;K. Tajima;T. Rohan

  • Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

    Nasim Mavaddat;Kyriaki Michailidou;Kyriaki Michailidou;Joe Dennis;Michael Lush

  • Association Between BRCA1 and BRCA2 Mutations and Survival in Women with Invasive Epithelial Ovarian Cancer

    Kelly L. Bolton;Kelly L. Bolton;Georgia Chenevix-Trench;Cindy Goh;Siegal Sadetzki

  • Laser scanning of forest resources: the nordic experience

    Erik Næsset;Terje Gobakken;Johan Holmgren;Hannu Hyyppä

  • A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

    Corine Bertolotto;Fabienne Lesueur;Sandy Giuliano;Thomas Strub

  • The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.

    A C Antoniou;A P Cunningham;J Peto;D G Evans

  • A Collaborative Survey of 80 Mutations in the BRCA1 Breast and Ovarian Cancer Susceptibility Gene: Implications for Presymptomatic Testing and Screening

    Donna Shattuck Eidens;Melody Mcclure;Jacques Simard;Fernand Labrie

  • Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence

    N. Hamajima;K. Hirose;K. Tajima;T. Rohan

  • Genome-wide association study identifies three loci associated with melanoma risk.

    D Timothy Bishop;Florence Demenais;Mark M Iles;Mark Harland

  • Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas

    Pierre Geborek;Anna Bladström;Carl Turesson;Anders Gulfe

Frequent Co-Authors

Åke Borg
Åke Borg Lund University
Roger L. Milne
Roger L. Milne Cancer Council Victoria
Graham G. Giles
Graham G. Giles University of Melbourne
Jenny Chang-Claude
Jenny Chang-Claude German Cancer Research Center
Irene L. Andrulis
Irene L. Andrulis University of Toronto
Douglas F. Easton
Douglas F. Easton University of Cambridge
Hiltrud Brauch
Hiltrud Brauch German Cancer Research Center
Melissa C. Southey
Melissa C. Southey Monash University
Anna Jakubowska
Anna Jakubowska Pomeranian Medical University
Göran Jönsson
Göran Jönsson Lund University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare can open up a range of rewarding and flexible careers. For those interested in administrative roles, medical billing and coding certification online offers an entry point into the healthcare industry with a focus on accurate record-keeping and insurance claim management. These programs are often shorter and more affordable than traditional degrees.

If direct patient care is your goal, pursuing a nursing career is a popular option. Wondering about affordability? You can find out how much is online nursing school and explore programs that fit your budget. For advanced practice roles, you may consider the cheapest np school online to become a nurse practitioner, providing more responsibility and autonomy in patient care.

Interested in leadership or research? Many experienced nurses pursue doctoral-level qualifications, and there are options for the cheapest phd nursing programs online. These programs can help you advance your career, often allowing for flexible study while you continue working.

Best Scientists Citing Håkan Olsson

Trending Scientists

Recently Published Articles